Protocol summary

Study aim
The aim of current study is to survey effects of adding trinitroglycerin (TNG) to the patient controlled intravenous analgesia pump in patients with lower limb orthopedic surgery
Design
Clinical trial study, with parallel groups, double blinded, randomized
Settings and conduct
75 patients who undergo surgery due to fracture of the lower limbs in Rasul Akram hospital were selected and were randomly per muted blocks and based on online randomization software, divided into three equal groups and received one of following analgesia methods via intravenous pain pump after the end of surgery in recovery: Control group: Without using Trinitriglycerin (TNG).  First intervention group: Using 500 microgram (mcg) Trinitriglycerin (TNG) in the pain pump. Second intervention group: Using 1000 mcg, TNG in the pain pump.  Pain in patients is measured 4, 8, 12 and 24 hours after surgery by Visual analogue scale.
Participants/Inclusion and exclusion criteria
Inclusion criteria: Lower extremities orthopedic patients, Spinal anesthesia with 15 milligram (mg) bupivacain 0.5%, Patients with American Society of Anesthesiologists (ASA) I,II. Exclusion criteria: Addiction to alcohol, benzodiazepines and opium, Heart failure, Patients dissatisfaction, Allergies to any of used drugs, Seizure, Valvular heart disease, Arrhythmia.
Intervention groups
First intervention group: Using 500 microgram (mcg) Trinitriglycerin (TNG) in the pain pump. (Nitral, Caspian Tamin Pharmaceutical Co.) Second intervention group: Using 1000 mcg, TNG in the pain pump. Control group: Pain pump without using TNG in the pain pump
Main outcome variables
Patient's pain 4, 8, 12 and 24 hours after surgery.

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20180922041088N1
Registration date: 2018-12-28, 1397/10/07
Registration timing: retrospective

Last update: 2018-12-28, 1397/10/07
Update count: 0
Registration date
2018-12-28, 1397/10/07
Registrant information
Name
Atossa Soltani
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 21 2201 4414
Email address
atossa61@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2017-09-01, 1396/06/10
Expected recruitment end date
2018-08-01, 1397/05/10
Actual recruitment start date
2017-10-07, 1396/07/15
Actual recruitment end date
2018-09-11, 1397/06/20
Trial completion date
2018-10-17, 1397/07/25
Scientific title
Effects of adding trinitroglycerin (TNG) to the patient controlled intravenous analgesia pump in patients with lower limb orthopedic surgery
Public title
Effects of nitroglycerine (TNG) in intravenous pain control pump
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Lower extremities orthopedic patients Spinal anesthesia with 15 milligram (mg) bupivacain 0.5% Patients with American Society of Anesthesiologists (ASA) I,II
Exclusion criteria:
Addiction to alcohol, benzodiazepines and opium. Heart failure Patients dissatisfaction Allergies to any of used drugs Seizure Valvular heart disease Arrhythmia
Age
From 18 years old to 50 years old
Gender
Both
Phase
3
Groups that have been masked
  • Participant
  • Outcome assessor
Sample size
Target sample size: 75
Actual sample size reached: 75
Randomization (investigator's opinion)
Randomized
Randomization description
First, individuals who have the characteristics necessary to enter the study are usually taken from a non-random sample using a simple sampling method. Then, randomization is done between study groups. In this study, a block randomization method (including 4 blocks) is used. One of the study partners who has not been blindfolded, named pain pump with and without TNG with the letters A and B. Then, the researcher will distribute A and B packages among patients in a randomized block method (ABAB, BABA, AABB, BBAA, ABBA, BAAB; A, first person; B, Second person; A, third person; B,fourth person B etc.). Then, selecting the blocks are continued until reaching the sample size. Random sequence generation was done using simple randomization. To construct a random sequence to the possible blocks (6 blocks), we give numbers to them from one to six numbers. According to the sample size, each number of 4 blocks required will be used. the number of blocks was chosen from the random numbers table and based on these numbers we identified the sequence of blocks in each group.
Blinding (investigator's opinion)
Double blinded
Blinding description
In this study blinding will be as follows: Researcher and data collector are the same and are blinded and unaware of the contents of the pain pumps. Patients: Are blinded because they are unaware of the contents of the pain pump. Blinding: Based on the sequence of random numbers, group A or B will be placed inside sealed envelopes. A researcher who does not know the contents and sequence of envelopes will open the envelopes accordingly, and based on the fact that A or B has arrived, they will use a pre-filled pump A or B, respectively. One of the members of the research team has put the A label or label B on the pumps (only the same person is aware of the contents inside the pump)
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics Committee of Iran University of Medical Sciences
Street address
Iran University of Medical Sciences., next to Milad Tower., Hemmat Highway
City
Tehran
Province
Tehran
Postal code
1449614535
Approval date
2017-11-01, 1396/08/10
Ethics committee reference number
IR.IUMS.FMD.REC 1396.9411174009

Health conditions studied

1

Description of health condition studied
pain control after surgery
ICD-10 code
M79.6
ICD-10 code description
Pain in limb, hand, foot, fingers and toes

Primary outcomes

1

Description
Pain after lower limb orthopedic surgery
Timepoint
4, 8, 12 and 24 hours after surgery
Method of measurement
Using Visual Analogue Scale

Secondary outcomes

1

Description
Complications
Timepoint
During 24 hours after surgery
Method of measurement
With physical examination

2

Description
Need for adjuvant analgesic
Timepoint
During 24 hours using pain pump
Method of measurement
Using questionnaire information

Intervention groups

1

Description
First intervention group: Patients will use 500 microgram (mcg) Trinitroglycerin (TNG)-containing pain pump to reduce pain after lower limb orthopedic surgery. (Nitral, Caspian Tamin Pharmaceutical Co.)
Category
Treatment - Drugs

2

Description
Control group: Patients will use without Trinitroglycerin (TNG)-containing pain pump to reduce pain after lower limb orthopedic surgery
Category
Treatment - Drugs

3

Description
Second intervention group: Patients will use 1000 microgram (mcg) Trinitroglycerin (TNG)-containing pain pump to reduce pain after lower limb orthopedic surgery. (Nitral, Caspian Tamin Pharmaceutical Co.)
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
Rasool Akram Hospital
Full name of responsible person
Poupak Rahim Zadeh
Street address
Department of pain، 4th Floor, Hazrat-E-Rasool Hospital, Iran University of Medical Sciences, Niayesh St.,Sattarkahn Ave., Tehran, Iran
City
Tehran
Province
Tehran
Postal code
1445613131
Phone
+98 21 6651 5001
Email
PR@iums.ac.ir

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Seyed Kazem Malakuti
Street address
Iran University of Medical Sciences., next to Milad Tower., Hemat Highway
City
Tehran
Province
Tehran
Postal code
1449614535
Phone
+98 21 8163 3685
Email
PR@iums.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Iran University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Poupak Rahimzadeh
Position
Associate professor
Latest degree
Subspecialist
Other areas of specialty/work
Anesthesiology
Street address
Fifth floor, Central staff, Iran University of Medical Sciences, Hemmat Highway
City
Tehran
Province
Tehran
Postal code
1916737183
Phone
+98 21 8670 2503
Fax
+98 21 6650 9059
Email
p-rahimzadeh@tums.ac.ir

Person responsible for scientific inquiries

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Poupak Rahimzadeh
Position
Associate professor
Latest degree
Subspecialist
Other areas of specialty/work
Anesthesiology
Street address
Fifth floor, Central staff, Iran University of Medical Sciences, Hemmat Highway
City
Tehran
Province
Tehran
Postal code
1916737183
Phone
+98 21 8670 2503
Fax
+98 21 6650 9059
Email
p-rahimzadeh@tums.ac.ir

Person responsible for updating data

Contact
Name of organization / entity
Iran University of Medical Sciences
Full name of responsible person
Poupak Rahimzadeh
Position
Associate professor
Latest degree
Subspecialist
Other areas of specialty/work
Anesthesiology
Street address
Fifth floor, Central staff, Iran University of Medical Sciences, Hemmat Highway
City
Tehran
Province
Tehran
Postal code
1916737183
Phone
+98 21 8670 2503
Fax
+98 21 6650 9059
Email
p-rahimzadeh@tums.ac.ir

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Undecided - It is not yet known if there will be a plan to make this available
Study Protocol
Undecided - It is not yet known if there will be a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Yes - There is a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Not applicable
Title and more details about the data/document
We have not yet set a conclusion
When the data will become available and for how long
We have not yet set a conclusion
To whom data/document is available
We have not yet set a conclusion
Under which criteria data/document could be used
We have not yet set a conclusion
From where data/document is obtainable
We have not yet set a conclusion
What processes are involved for a request to access data/document
We have not yet set a conclusion
Comments
Loading...